September 2017

Third Circuit Allows Spector Partners to Proceed with Effexor claims The Third Circuit Court of Appeals has just reversed dismissal of antitrust claims against Pfizer and Teva over the blood thinner Aggranox and its generic equivalents. Spector Partners is co-lead counsel in the case, alleging that Pfizer took anti-competitive actions […]

Spector Partners Wins Class Certification, Defeats Summary Judgment in Liquidity Services, Inc. Securities Class Action On September 6, 2017, the United States District Court for the District of Columbia granted co-lead counsel Spector Partners’ motion to certify a class of investors who purchased the common stock of Liquidity Services, Inc.